Jingqin Luo

Jul 2, 2024 | nature.com | Jingqin Luo |Erik D. Roberson |Carlos Cruchaga |David M. Holtzman |Randall J. Bateman

AbstractBlood-based biomarkers of Alzheimer disease (AD) may facilitate testing of historically under-represented groups. The Study of Race to Understand Alzheimer Biomarkers (SORTOUT-AB) is a multi-center longitudinal study to compare AD biomarkers in participants who identify their race as either Black or white. Plasma samples from 324 Black and 1,547 white participants underwent analysis with C2N Diagnostics’ PrecivityAD test for Aβ42 and Aβ40.